InsideTrading SEC Form 4 insider trades

Stocks

REPL Replimune Group, Inc.

Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $2.1B

–

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.